This article aims to clear any doubts and questions you may have about this subject and we will do our best to do so.
Save Citation To File
Boots Health Hub
Do not let the tip of the dropped come in to contact with the eye
Do not use if you are allergic to any of the ingredients
Do not use the product after the expiry date, see base of carton
Discard the product 30 days after first opening
Do not use with other eye preparations
Keep out of sight and reach of children
Store between 5°C to 30°C and out of direct sunlight.
Login To Your Account
Of vitamin E acetate (VEA) eye drops on naphthalene-induced cataract in rats was investigated by Scheimpflug image analysis. During those 9 weeks, the changes of the crystalline lens were documented by an anterior eye segment analysis system (EAS-1000, NIDEK) once a week in mydriasis (Mydrin®-P, Santen Pharmaceutical Co, Ltd.).
The characteristic density values of the anterior deeper cortex regions were measured. This difference was found 1 week, 4 weeks, and from 7 to 9 weeks after the start of naphthalene application. Vea eye drops may have the potential to delay the progression of naphthalene-induced cataract in rat.
To determine whether treatment with vitamin E (500 IU daily) reduces either the incidence or rate of progression of age-related cataracts. Intervention
Subjects were assigned randomly to receive either 500 IU of natural vitamin E in soybean oil encapsulated in gelatin or a placebo with an identical appearance. The analysis was undertaken using data from the eye with the more advanced opacity for each type of cataract separately and for any cataract changes in each individual.
Overall, 87% of the study population completed the 4 years of follow-up, with 74% of the vitamin E group and 76% of the placebo group continuing on their randomized treatment allocation throughout this time. Conclusions
Vitamin E given for 4 years at a dose of 500 IU daily did not reduce the incidence of or progression of nuclear, cortical, or posterior subcapsular cataracts.